The Venture Codex Logo

The Venture Codex

Overview

Developer of oncology drugs targeting tumor cell vulnerabilities.

Total Raised

$151 M

Rounds

2

Links

Verticals

Biotechnology
Health Care
Oncology
Pharmaceutical
Therapeutics

Investment History

  1. Series B

    Sep 2019

    $83M

  2. Series A

    Jun 2017

    $68M

Team

Lloyd Segal

President & Chief Executive Officer

Frank Sicheri

Co-Founder

Agnel Sfeir

Co Founder

Daniel Durocher

Founder